Evidence map›Paper›PMID 39215335›Full record

ArticleMolecular brain2024

Altered brain connectivity in mild cognitive impairment is linked to elevated tau and phosphorylated tau, but not to GAP-43 and Amyloid-β measurements: a resting-state fMRI study.

Mohammad Sadeghi, Ali Azargoonjahromi, Hamide Nasiri, Arash Yaghoobi, Maryam Sadeghi, Seyedeh Saeideh Chavoshi, Shilan Baghaeikia, Nastaran Mahzari, Arina Valipour, Romina Razeghi Oskouei and 3 more

Abstract read
In one paragraph

Article in Molecular brain, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Mohammad SadeghiSchool of Rehabilitation, Shiraz University of Medical Sciences, Shiraz, Iran.ORCID 0000-0003-0351-7876
Ali AzargoonjahromiShiraz University of Medical Sciences, Shiraz, Iran. aazargoonj@gmail.com.ORCID 0000-0002-6997-9419
Hamide NasiriSchool of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
Arash YaghoobiSchool of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Maryam SadeghiDepartment of Nuclear Medicine, Children Medical Center Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Seyedeh Saeideh ChavoshiImam Khomeini International University, Qazvin, Iran.
Shilan BaghaeikiaFaculty of the Veterinary Medicine, University of Tehran, Tehran, Iran.
Nastaran MahzariDepartment of Pharmacy, School of Pharmacy, International Campus, Tehran University of Medical Sciences, Tehran, Iran.
Arina ValipourSchool of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran.
Romina Razeghi OskoueiDepartment of clinical laboratory sciences, Qazvin University of medical sciences, Qazvin, Iran.
Farshad ShahkaramiDepartment of Internal Medicine, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Fatemeh AmiriStudent Research Committee, Afzalipour Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran.
Mahsa MayeliSchool of Medicine, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0003-4656-156X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mild Cognitive Impairment (MCI) is a neurological condition characterized by a noticeable decline in cognitive abilities that falls between normal aging and dementia. Along with some biomarkers like GAP-43, Aβ, tau, and P-tau, brain activity and connectivity are ascribed to MCI; however, the link between brain connectivity changes and such biomarkers in MCI is still being investigated. This study explores the relationship between biomarkers like GAP-43, Aβ, tau, and P-tau, and brain connectivity. We enrolled 25 Participants with normal cognitive function and 23 patients with MCI. Levels of GAP-43, Aβ1-42, t-tau, and p-tau181p in the CSF were measured, and functional connectivity measures including ROI-to-voxel (RV) correlations and the DMN RV-ratio were extracted from the resting-state fMRI data. P-values below 0.05 were considered significant. The results showed that in CN individuals, higher connectivity within the both anterior default mode network (aDMN) and posterior DMN (pDMN) was associated with higher levels of the biomarker GAP-43. In contrast, MCI individuals showed significant negative correlations between DMN connectivity and levels of tau and P-tau. Notably, no significant correlations were found between Aβ levels and connectivity measures in either group. These findings suggest that elevated levels of GAP-43 indicate increased functional connectivity in aDMN and pDMN. Conversely, elevated levels of tau and p-tau can disrupt connectivity through various mechanisms. Thus, the accumulation of tau and p-tau can lead to impaired neuronal connectivity, contributing to cognitive decline.

Indexed as

Amyloid beta-PeptidesBrainCognitive DysfunctionGAP-43 ProteinMagnetic Resonance ImagingResttau ProteinsAgedBiomarkersFemaleHumansMaleMiddle AgedPhosphorylationAmyloid beta-PeptidesBiomarkersGAP-43 Proteintau ProteinsAmyloid βBrain connectivityDefault mode networkGAP-43Mild cognitive impairmentTau protein

Identifiers

PMID39215335
PMCPMC11363600

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.